EasyMed Signs the Dow Chemical Company to Trial of International Medical
Executives of leading science and technology company, Dow, will
benefit from having their medical records on their smartphones
wherever they travel
GENEVA, SWITZERLAND -- (Marketwire) -- 02/07/13 -- EasyMed Services
Inc. (CNSX:EZM)(PINKSHEETS:EMYSF)(MUN:EY6) (www.EasyMedMobile.com)
today announced that the Dow Chemical Company has signed for a trial
of the International Medical Passport for its executive staff in
The International Medical Passport is viewed as an excellent
added-value benefit for the company's executives, particularly
considering the company's customers in 160 countries. The trial will
be implemented as a first step to allow staff to securely download
their medical files on to their smartphones.
Dow was originally conceived in 1890 by Herbert H. Dow and now
consists of an industry-leading portfolio of specialty chemical,
advanced materials, agrosciences and plastics businesses, delivering
a broad range of technology-based products and solutions. The company
works with customers in approximately 160 countries in high growth
sectors such as electronics, water, energy, coatings and agriculture.
Mr. Tejinder Sahota, CEO of EasyMed Services said, "After having
signed up Chanel, we are very pleased to be able to secure the Dow
Chemical Company for a trial of the International Medical Passport.
This is another milestone in our B2B strategy as we continue to
develop our direct to consumer model."
EasyMed Services' primary focus is to rise to the opportunity
presented by the French initiative towards the adoption of mobile
Mr. Sahota continues, "Dow is a leading player in the chemicals
industry, manufacturing more than 5,000 products at 197 sites in 36
countries and with approximately 52,000 employees worldwide; the
company had sales in 2011 of $60bn. As well as being a great
innovator in its own field, Dow has had the vision to provide their
executives with EasyMed's cutting-edge medical technology. We look
forward to working with them during this trial with a view to a
company-wide rollout in the future."
International Medical Passport
EasyMed's International Medical Passport
medical records accessible worldwide by smartphone - an important
service for all business travelers. Today's global travelers need
instant access to their health records in case of an emergency. The
International Medical Passport puts the complete record on a
smartphone together with instant access to pre-approved doctors,
clinics and hospitals around the world. The Medical Passport works on
all phone, PDA and web platforms and operates in over 80 countries
with 300+ mobile carriers. Cloud-based, secure, compliant and
accessible on iPhone, Android, Windows and Blackberry platforms,
EasyMed's International Medical Passport meets HIPAA requirements,
supports HL-7 (the global authority on standards for interoperability
of health information technology) and is IBM certified.
About Dow Chemcial
Dow is truly a global company with the scale and expertise to solve
challenging problems for customers and society. Our diversified,
industry-leading portfolio of specialty chemical, advanced materials,
agrosciences and plastics businesses deliver a broad range of
technology-based products and solutions to customers in approximately
160 countries and in high-growth sectors such as electronics, water,
energy, coatings and agriculture. In 2011, Dow posted annual sales of
$60 billion and EBITDA of approximately $8.4 billion. For
information, please visit www.dow.com.
About EasyMed Services Inc.
EasyMed Services Inc. (CNSX:EZM)(PINKSHEETS:EMYSF)(MUN:EY6) is a
global medical information technology company delivering an
end-to-end patient care solution through mobile phone, PDA and server
technologies offering specialized services and applications for
healthcare, insurance and pharmaceutical industries. We are committed
to world-class customer service and the protection of our clients'
information. To learn more, please visit www.EasyMedMobile.com.
This news release may contain forward-looking statements, which
relate to future events or future performance, such as the continuing
roll-out of the Company's primary product and the benefits of such
products that may be realized by the Company's targeted customers,
and reflect management's current expectations and assumptions about
such future events or future performance. Forward-looking statements
may also include, without limitation, any statement relating to
future conditions or circumstances. These forward-looking statements
reflect management's current beliefs and are based on assumptions
made by and information currently available to the Company and its
management. Investors are cautioned that these forward looking
statements are neither promises nor guarantees, and are subject to
risks and uncertainties that may cause future results to differ
materially from those expected. These forward-looking statements are
made as of the date hereof and, except as required under applicable
securities legislation, the Company does not assume any obligation to
update or revise them to reflect new events or circumstances or to
reflect changes in the beliefs or opinions of the Company's
The CNSX has not reviewed this release and therefore does not accept
responsibility for the adequacy or accuracy of this release.
Jared W. Scharf
EasyMed Services Inc.
Press spacebar to pause and continue. Press esc to stop.